APA (7th ed.) Citation

Klamroth, R., Miesbach, W., & Staritz, P. (2016). Prospective evaluation of treatment regimens, efficacy and safety of a recombinant factor VIII concentrate in haemophilia A: The German EffeKt study. Haemophilia, 22(5), 684. https://doi.org/10.1111/hae.12941

Chicago Style (17th ed.) Citation

Klamroth, R., W. Miesbach, and P. Staritz. "Prospective Evaluation of Treatment Regimens, Efficacy and Safety of a Recombinant Factor VIII Concentrate in Haemophilia A: The German EffeKt Study." Haemophilia 22, no. 5 (2016): 684. https://doi.org/10.1111/hae.12941.

MLA (9th ed.) Citation

Klamroth, R., et al. "Prospective Evaluation of Treatment Regimens, Efficacy and Safety of a Recombinant Factor VIII Concentrate in Haemophilia A: The German EffeKt Study." Haemophilia, vol. 22, no. 5, 2016, p. 684, https://doi.org/10.1111/hae.12941.